Acquired Immune Deficiency Syndrome: An Evaluation of the Federal Role : Hearing Before a Subcommittee of the Committee on Appropriations, United States Senate, One Hundredth Congress, First Session, Special Hearing

Front Cover
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Other editions - View all

Common terms and phrases

Popular passages

Page 10 - First, the distribution of cases of AIDS and AIDS-related complex by diagnosis may change over time. For example, according to CDC, the proportion of AIDS patients with certain cancers, such as Kaposi's sarcoma, may decrease while severe lung infections, such as pneumocystis carinii pneumonia, may increase. Since the latter is more expensive to treat, direct personal medical costs would be expected to rise. Other changes in casemix may also raise or lower total treatment costs. Second, numerous drugs...
Page 122 - Brazil, the only South American country covered in the eradication campaign, has the highest incidence of Aids in that region. About 14,000 Haitians, on United Nations secondment to Central Africa, were covered in the campaign. They began to return home at a time when Haiti had become a popular playground for San Francisco homosexuals.
Page 8 - AIDS education should be pursued with a sense of urgency and a level of funding that is appropriate for a life-or-death situation.
Page 9 - ... million individuals. According to lOM's report, however, more than 10 million persons may be candidates for testing. Recent CDC data on the estimated populations at high risk of HIV infection — homosexual/bisexual men, IV drug users, and heterosexuals at high risk — approach 10 million persons. At an average cost of $45 per person, potential resources needed if these individuals request testing would approach $450 million. Assuming federal and state resources of about $184 million, over $250...
Page 122 - The link between the WHO program and the epidemic is an interesting and important hypothesis. I cannot say that it actually happened, but I have been saying for some years that the use of live vaccines such as that used for smallpox can activate a dormant infection such as HIV (the AIDS virus).
Page 3 - AZT (azidothymidine) affect treatment costs in two ways — by raising pharmaceutical costs and by changing the clinical course of the disease. Patients on this drug may live longer but require different health care services, which may in turn raise or lower costs. Moreover, drugs like AZT may improve the quality of life and decrease productivity losses if AIDS patients can continue to work longer than would have been possible without the drug.
Page 6 - ... of the cases were clustered in highincidence areas, such as New York City, San Francisco, Los Angeles, Miami, and Houston. The Public Health Service predicts that there will be a total of 270,000 cases by 1991. While San Francisco and New York currently account for over half the cases, by 1991, 80 percent of the cases are predicted to be in other areas. The Public Health Service's budget for AIDS prevention and research has increased from $200,000 in fiscal year 1981 to over $790 million proposed...
Page 122 - The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox Eradication (Geneva, December 1979).
Page 57 - THE DEPARTMENT OF PEDIATRICS at the University of Miami School of Medicine seeks a PRIMARY CARE PEDIATRICIAN, to join the faculty, with an interest in working with high risk children in community settings.
Page 3 - ... by diagnosis may change over time. This may raise or lower costs. For example, according to CDC, the proportion of AIDS patients with Kaposi's sarcoma may decrease while pneumocystis carinii pneumonia may increase. Since the latter is more expensive to treat, direct personal medical costs would be expected to rise. Other changes in case-mix may also raise or lower total treatment costs. Second, changes in medical treatment are constantly occurring, particularly in highincidence cities.

Bibliographic information